Tech Company Financing Transactions
Mercator MedSystems Funding Round
On 6/22/2018, Mercator MedSystems raised $11 million in Series D funding from Shenzhen Salubris Pharmaceuticals and private investors.
Transaction Overview
Company Name
Announced On
6/22/2018
Transaction Type
Venture Equity
Amount
$11,000,000
Round
Series D
Investors
Shenzhen Salubris Pharmaceuticals (Lead Investor) (Kevin Ye)
Proceeds Purpose
The new funding will further advance the clinical development of Mercator's proprietary micro-infusion catheter systems and accelerate the company's vision of improving outcomes in patients around the world with cardiovascular and pulmonary disease.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1900 Powell St. 800
Emeryville, CA 94608
USA
Emeryville, CA 94608
USA
Phone
Website
Email Address
Overview
Mercator MedSystems, Inc., based in San Leandro, Calif., is a privately held medical technology company focused on commercializing catheter-guided, microfluid infusion systems for site-specific delivery of therapeutic agents for applications to vascular disease, oncology and regenerative medicine.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Trent Reutiman
Chief Financial Officer
Steve Baker
Chief Technical Officer
Kirk Seward
Browse more venture capital transactions:
Prev: 6/22/2018: Agari venture capital transaction
Next: 6/22/2018: Innovapptive venture capital transaction
Share this article
News on VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs